Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity
Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 52, pp. 17986-17996
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 985
Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications
Nan Xiao, Meng Nie, Huanhuan Pang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 236
Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
Bindu D. Paul, Marian Dix Lemle, Anthony L. Komaroff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 34
Open Access | Times Cited: 205
Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mario Mehmel, Nina Jovanović, Urs Spitz
Nutrients (2020) Vol. 12, Iss. 6, pp. 1616-1616
Open Access | Times Cited: 182
Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19
Xiaojie Bi, Wei Liu, Xuan Ding, et al.
Cell Reports (2021) Vol. 38, Iss. 3, pp. 110271-110271
Open Access | Times Cited: 113
Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 79
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase
Yousef M. Alhammad, M.M. Kashipathy, Anuradha Roy, et al.
Journal of Virology (2020) Vol. 95, Iss. 3
Open Access | Times Cited: 121
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, et al.
iScience (2020) Vol. 23, Iss. 10, pp. 101631-101631
Open Access | Times Cited: 104
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
Aikaterini Nasi, Stéphanie McArdle, Gustav Gaudernack, et al.
Toxicology Reports (2020) Vol. 7, pp. 768-771
Open Access | Times Cited: 96
Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Ole Kristian Reiten, Martin Andreas Wilvang, Sarah J. Mitchell, et al.
Mechanisms of Ageing and Development (2021) Vol. 199, pp. 111567-111567
Open Access | Times Cited: 93
Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients
Judith Marín‐Corral, Jose Rodríguez‐Morató, Àlex Gomez‐Gómez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4794-4794
Open Access | Times Cited: 77
Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Özlem Altay, Muhammad Arif, Xiangyu Li, et al.
Advanced Science (2021) Vol. 8, Iss. 17
Open Access | Times Cited: 70
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 68
A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection
David A. Jamison, S Narayanan, Nídia S. Trovão, et al.
European Journal of Human Genetics (2022) Vol. 30, Iss. 8, pp. 889-898
Open Access | Times Cited: 66
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
Keisuke Okabe, Keisuke Yaku, Yoshiaki Uchida, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 63
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+
Jureepon Roboon, Tsuyoshi Hattori, Hiroshi Ishii, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 2, pp. 311-327
Open Access | Times Cited: 60
Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 54
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Julianna D. Zeidler, Kelly A. Hogan, Guillermo Agorrody, et al.
AJP Cell Physiology (2022) Vol. 322, Iss. 3, pp. C521-C545
Open Access | Times Cited: 49
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes
Jing Wu, Komudi Singh, Amy Lin, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 46
NAD+ in COVID-19 and viral infections
Minyan Zheng, Michael Schultz, David Sinclair
Trends in Immunology (2022) Vol. 43, Iss. 4, pp. 283-295
Open Access | Times Cited: 43
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Yisheng Jiang, Yong‐Qiang Deng, Huanhuan Pang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Tryptophan metabolism and disposition in cancer biology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 42
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
Gabriela Fabiana Soares Alegre, Gláucia María Pastore
Current Nutrition Reports (2023) Vol. 12, Iss. 3, pp. 445-464
Open Access | Times Cited: 37
DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids
Kang Zhu, Marcin J. Suskiewicz, Chatrin Chatrin, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 2, pp. 801-815
Open Access | Times Cited: 24
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, et al.
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100733-100733
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top